0001062993-24-003644.txt : 20240220
0001062993-24-003644.hdr.sgml : 20240220
20240220161225
ACCESSION NUMBER: 0001062993-24-003644
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ricciardi Lisa
CENTRAL INDEX KEY: 0001418200
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40886
FILM NUMBER: 24653414
MAIL ADDRESS:
STREET 1: C/O COGNITION THERAPEUTICS, INC
STREET 2: 2500 WESTCHESTER AVENUE
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COGNITION THERAPEUTICS INC
CENTRAL INDEX KEY: 0001455365
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2403 SIDNEY STREET
STREET 2: SUITE 261
CITY: PITTSBURGH
STATE: PA
ZIP: 15203
BUSINESS PHONE: 412-481-2210
MAIL ADDRESS:
STREET 1: 2500 WESTCHESTER AVE
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: COGNITION THERAPUTICS INC
DATE OF NAME CHANGE: 20090204
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-02-15
0001455365
COGNITION THERAPEUTICS INC
CGTX
0001418200
Ricciardi Lisa
C/O COGNITION THERAPEUTICS INC
2403 SIDNEY STREET, SUITE 261
PITTSBURGH
PA
15203
1
1
0
0
CEO & President
0
Common Stock
2024-02-15
4
A
0
75000
0.00
A
285645
D
Stock Option (Right to Buy)
1.98
2024-02-15
4
A
0
75000
0.00
A
2034-02-15
Common Stock
75000
75000
D
Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
The option vests 25% on February 15, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.
Exhibit 24 - Power of Attorney
/s/ Lisa Ricciardi
2024-02-20
EX-24.1
2
exhibit24-1.txt
POA
POWER OF ATTORNEY
Know by all these presents, that the undersigned hereby constitutes
and appoints John Doyle, signing singly, and with full power of
substitution, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of Cognition
Therapeutics, Inc. (the "Company"), Forms 3, 4, and 5, and any
amendments or supplements to such Forms, in accordance with Section
16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete
and execute any such Form 3, 4, and 5, or amendments or
supplements thereto, and timely file such Forms, amendments and
supplements with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with
the foregoing which,in the opinion of such attorney-in-fact, may be
in the best interest of, or legally required by, the undersigned,
it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this
Power of Attorney shall be in such form and shall contain
such terms and conditions as such attorney-in-fact may approve.
The undersigned hereby grants to the attorney-in-fact full
power and authority to take any action whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as
the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or her substitute, shall lawfully
do or cause to be done by virtue of this Power of Attorney.
The undersigned acknowledges that the foregoing attorney-in-fact,
in serving in such capacity at the request of the undersigned, is not
assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with Section 16 of the Securities Exchange
Act of 1934 or the rules thereunder.
This Power of Attorney shall remain in full force and effect until
the undersigned is no longer required to file Forms 3, 4, and
5 with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing delivered to the
foregoing attorney-in-fact or the Company. By executing this Power
of Attorney, the undersigned hereby revokes all prior powers of
attorney executed by the undersigned with respect to the execution
of Forms 3, 4, and 5 with respect to the undersigned's holdings of
and transactions in securities issued by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of February 16, 2024.
/s/ Lisa Ricciardi
Signature
Lisa Ricciardi
Print Name